Kilonzo, MaryBoyers, DwayneCooper, DavidDavidson, TraceyBhal, KironN'Dow, JamesMacLennan, GraemeNorrie, JohnAbdel-Fattah, Mohamed2023-11-302023-11-302024-02-01Kilonzo, M, Boyers, D, Cooper, D, Davidson, T, Bhal, K, N'Dow, J, MacLennan, G, Norrie, J & Abdel-Fattah, M 2024, 'Three-year cost utility analysis of mini versus standard slings : A trial based economic evaluation', BJUI Compass, vol. 5, no. 2, pp. 230-239. https://doi.org/10.1002/bco2.3032688-4526ORCID: /0000-0002-1039-5646/work/148047449ORCID: /0000-0001-5340-0081/work/162725295ORCID: /0000-0002-3450-4536/work/170010807https://hdl.handle.net/2164/22315Open access via the Wiley Agreement Dr. Dwayne Boyers reports grants from UK NIHR during the conduct of the study. Ms. Mary Kilonzo reports grants from UK NIHR during the conduct of the study. Kiron Bhal: I have been a speaker and trainer for the following companies in the past Astellas, Pfizer, AMS, Contura, Allergan and others, where I have received honorariums and sponsorship towards attending scientific conferences. Professor James N'Dow reports HTA General Committee 2016–2018. Professor Graeme MacLennan reports grants from UK NIHR during the conduct of the study. Professor John Norrie reports grants from the University of Edinburgh, outside the submitted work; and past and present member of the following: HTA Commissioning Sub‐Board (EOI), NIHR CTU Standing Advisory Committee, NIHR HTA & EME Editorial Board, Pre‐Exposure Prophylaxis Impact Review Panel, EME Strategy Advisory Committee, EME—Funding Committee Members, EME Funding Committee Sub‐Group Remit & Comp Check, HTA General Committee, HTA Funding Committee Policy Group (formerly CSG) and HTA Commissioning Committee. HTA post‐funding committee teleconference 2016–2019; COVID‐19 reviewing 2020. Professor Mohamed Abdel‐Fattah: None in the last 5 years. Before 2015, I have been a speaker, consultant and/or surgical trainer for a number of industrial companies (Astellas, Ethicon, Bard, Pfizer, AMS, Coloplast and others): I have been reimbursed my travel expenses; and on occasions received personal honorariums; proctorship fees and sponsorship towards attending scientific conferences. Research grant from Coloplast managed by the University of Aberdeen. A limited number of my trainees attended pharmaceutical‐sponsored educational/leadership workshops and/or received assistance in presenting their research work at scientific conferences. Was Chairman of the Scottish Pelvic Floor Network (SPFN), which at the time received financial sponsorship from various industrial companies (including all those mentioned above) and non‐profit organisations for its annual meetings and surgical workshops. The SPFN provided an educational grant funding the PI at the highest recruiting site to attend the International Continence Society annual scientific conference in Brazil in 2014. Ongoing: I receive travel sponsorship and occasionally speaker‘s fees from numerous national and international conferences and non‐profit organisations when invited as a guest speaker and/or expert surgeon. In 2019, and at request from NHS Grampian, I attended 2 educational meetings for setting up sacral nerve stimulation service partially funded by Medtronic. I am the Chief Investigator for four NIHR—HTA‐funded studies. I do not hold (and never held) any shares (or similar) in any of the industrial companies (medical or non‐medical). To the best of my knowledge, none of the above have influenced my research or clinical practice. Publisher Copyright: © 2023 The Authors. BJUI Compass published by John Wiley & Sons Ltd on behalf of BJU International Company.10234605engSDG 3 - Good Health and Well-beingcost utility analysiscost-effectiveness analysisQALYsstress urinary incontinenceR MedicineUrologyOncologySurgeryNephrologySupplementary InformationRJournal article10.1002/bco2.303http://www.scopus.com/inward/record.url?scp=85176783382&partnerID=8YFLogxK52